Press release
Substance Use Disorder Market is expected to reach USD 33.4 billion by 2034
Substance Use Disorder (SUD) is a complex, chronic condition characterized by compulsive use of drugs or alcohol despite harmful consequences. It encompasses dependence on substances such as opioids, alcohol, cannabis, stimulants, and sedatives. SUD significantly impacts public health, contributing to rising healthcare costs, loss of productivity, and increased mortality rates.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70806
The SUD market includes pharmacological therapies, behavioral interventions, harm-reduction strategies, rehabilitation services, and emerging digital therapeutics. Growing global awareness, favorable government initiatives, and innovation in long-acting and patient-centric treatments are reshaping the market landscape.
Market Overview
The global substance use disorder market was valued at USD 18.6 billion in 2024 and is projected to reach USD 33.4 billion by 2034, growing at a CAGR of 6.1%.
Key Market Highlights
• Rising prevalence of drug and alcohol misuse across both developed and emerging regions.
• Expansion of evidence-based treatment protocols integrating medication and behavioral therapy.
• Increased adoption of harm-reduction programs, including needle exchange and supervised consumption facilities.
Challenges
• Stigma and underreporting limit patient access to care.
• Unequal distribution of treatment infrastructure.
• High relapse rates without sustained long-term support.
Segmentation Analysis
By Substance Type
• Alcohol Use Disorder
• Opioid Use Disorder
• Tobacco/Nicotine Dependence
• Cannabis Use Disorder
• Stimulant Use Disorder (methamphetamine)
• Others
By Treatment Type
• Pharmacological Therapies
o Disulfiram, naltrexone, acamprosate (alcohol dependence)
o Buprenorphine, methadone, naltrexone (opioids)
o Nicotine replacement therapy, varenicline, bupropion (tobacco)
• Behavioral Therapies
o Cognitive Behavioral Therapy (CBT)
o Motivational Interviewing (MI)
o Contingency Management (CM)
• Digital Therapeutics
By End-User
• Hospitals
• Rehabilitation Centers
• Outpatient Clinics
• Specialty Addiction Treatment Facilities
Summary:
Pharmacological treatment is often combined with behavioral therapy for best outcomes, and digital therapeutics are emerging as scalable, cost-effective adjuncts.
Explore Full Report here: https://exactitudeconsultancy.com/reports/70806/substance-use-disorder-market
Regional Analysis
North America
• Largest market share, led by the U.S., where SUD treatment is supported by comprehensive public health programs and expanding insurance coverage.
• Strong adoption of telehealth-based addiction treatment.
Europe
• Robust integration of harm-reduction and rehabilitation services into public healthcare systems.
• The UK, Germany, and France are key markets.
Asia-Pacific
• Fastest-growing region due to rising drug and alcohol use in urban centers and increasing healthcare investment.
• Australia and New Zealand lead in policy innovation and treatment adoption.
Latin America
• Growing adoption of community-based rehabilitation, with Brazil and Mexico as primary markets.
Middle East & Africa
• Smaller market share but increasing attention to drug prevention and rehabilitation infrastructure in urban centers.
Summary:
While North America and Europe lead in infrastructure and technology adoption, Asia-Pacific offers the highest growth potential over the next decade.
Market Dynamics
Key Growth Drivers
• Increasing prevalence of alcohol, opioid, and stimulant misuse.
• Greater acceptance of medication-assisted treatment (MAT) as standard care.
• Innovation in extended-release, implantable, and digital therapeutic options.
• Government-led harm-reduction and decriminalization initiatives improving access.
Key Challenges
• Persistent stigma around addiction treatment.
• Shortage of trained healthcare providers specializing in SUD.
• High rates of relapse without continuous, holistic care.
Latest Trends
• Integration of wearable devices and mobile apps for real-time relapse prevention.
• AI-powered patient monitoring for early intervention.
• Wider insurance coverage for outpatient and telehealth addiction programs.
• Policy shifts toward public health-centered approaches over punitive measures.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70806
Competitive Landscape
Major Players
• Indivior PLC
• Alkermes plc
• Pfizer Inc.
• Camurus AB
• Braeburn Inc.
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
Competitive Strategies
• Development of long-acting, patient-friendly drug delivery systems.
• Partnerships with telemedicine providers for remote SUD care.
• Expansion into emerging markets with affordable treatment solutions.
• Educational campaigns aimed at reducing stigma and promoting treatment-seeking behavior.
Conclusion
The substance use disorder market is undergoing transformation as stigma decreases, treatment access widens, and innovation accelerates. The next decade will see a stronger emphasis on personalized, long-term care models that address both the medical and social dimensions of recovery.
Key Takeaways:
• CAGR of 6.1% through 2034 reflects strong, sustained market growth.
• North America and Europe dominate, but Asia-Pacific offers the fastest expansion potential.
• Integration of digital health tools will be a key differentiator for providers.
• Success will depend on expanding access, reducing stigma, and delivering patient-centered care.
This report is also available in the following languages : Japanese (物質使用障害市場), Korean (약물 사용 장애 시장), Chinese (物质使用障碍市场), French (Marché des troubles liés à la consommation de substances), German (Markt für Substanzstörungen), and Italian (Mercato dei disturbi da uso di sostanze), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/70806/substance-use-disorder-market#request-a-sample
Our More Reports:
USB Docking Station Market
https://exactitudeconsultancy.com/reports/62817/global-usb-docking-station-market
AMB Ceramic Substrate Market
https://exactitudeconsultancy.com/reports/62833/global-amb-ceramic-substrate-market
Passive Electronic Components Market
https://exactitudeconsultancy.com/reports/62853/global-passive-electronic-components-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Substance Use Disorder Market is expected to reach USD 33.4 billion by 2034 here
News-ID: 4142111 • Views: …
More Releases from Exactitude Consultancy

Opioid Use Disorder Market is expected to reach USD 6.6 billion by 2034
The OUD market encompasses pharmacological treatments, behavioral therapies, harm-reduction strategies, and rehabilitation services. Growing awareness, increased government initiatives, and the introduction of new treatment options are driving significant changes in how OUD is addressed worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70804
Market Overview
The global opioid use disorder market was valued at USD 3.7 billion in 2024 and is projected to reach USD 6.6 billion by 2034, growing at…

Intoxication Market to Reach USD 3.4 Billion by 2034
The intoxication market spans pharmaceuticals, emergency care interventions, diagnostics, and harm-reduction programs. Market expansion is being driven by increasing prevalence, heightened public health awareness, and advancements in acute care management.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70802
Market Overview
The global coc.... intoxication market was valued at USD 1.9 billion in 2024 and is projected to reach USD 3.4 billion by 2034, growing at a CAGR of 6.0%.
Key Market Highlights
• Rising…

Septic Shock Market to Reach USD 6.4 Billion by 2034
Septic shock, a severe and potentially fatal condition arising from overwhelming infection and systemic inflammation, remains one of the most critical emergencies in intensive care units (ICUs). Characterized by dangerously low blood pressure, organ dysfunction, and high mortality rates, septic shock requires rapid diagnosis, aggressive treatment, and multidisciplinary care.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70798
The septic shock market encompasses pharmaceuticals, diagnostics, monitoring devices, and supportive care solutions.…

Refractory Epilepsy Market to Reach USD 5.3 Billion by 2034
Refractory epilepsy-also known as drug-resistant epilepsy-is a severe neurological condition where seizures persist despite adequate trials of two or more appropriate antiepileptic drugs (AEDs). Affecting roughly one-third of epilepsy patients, this condition significantly impacts quality of life, increases the risk of injury and comorbidities, and presents a challenge for clinicians worldwide.
The market for refractory epilepsy treatments is expanding, driven by new pharmacological agents, advanced neurostimulation devices, surgical innovations, and personalized…
More Releases for Disorder
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope:
Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market
In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics …
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.
Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors…
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms…